v3.26.1
CONDENSED CONSOLIDATED STATMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2025   232,888      
Beginning balance at Jan. 31, 2025 $ 227,523 $ 2 $ 2,059,848 $ (3,851) $ (1,828,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   354      
Issuance of common stock upon the exercise of stock options 1,257   1,257    
Repurchases and retirement of common stock (in shares)   (1,034)      
Repurchases and retirement of common stock (15,606)       (15,606)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   2,261      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Issuance of common stock under employee share purchase plan (in shares)   751      
Issuance of common stock under employee share purchase plan 7,746   7,746    
Stock-based compensation expense 49,596   49,596    
Net unrealized (losses) gains on marketable securities 1,064     1,064  
Foreign currency translation adjustments 4,742     4,742  
Net loss (40,018)       (40,018)
Ending balance (in shares) at Apr. 30, 2025   235,220      
Ending balance at Apr. 30, 2025 236,304 $ 2 2,118,447 1,955 (1,884,100)
Beginning balance (in shares) at Jan. 31, 2026   237,915      
Beginning balance at Jan. 31, 2026 $ 154,117 $ 2 2,299,616 4,205 (2,149,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares) 280 280      
Issuance of common stock upon the exercise of stock options $ 686   686    
Repurchases and retirement of common stock (in shares)   (7,368)      
Repurchases and retirement of common stock (44,985)       (44,985)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   2,256      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Issuance of common stock under employee share purchase plan (in shares)   818      
Issuance of common stock under employee share purchase plan 4,874   4,874    
Stock-based compensation expense 38,242   38,242    
Net unrealized (losses) gains on marketable securities (1,009)     (1,009)  
Foreign currency translation adjustments (538)     (538)  
Net loss (14,405)       (14,405)
Ending balance (in shares) at Apr. 30, 2026   233,901      
Ending balance at Apr. 30, 2026 $ 136,982 $ 2 $ 2,343,418 $ 2,658 $ (2,209,096)